• Shanfei Zhao, Wenling Zheng, Xinru Gu, Guanglin Liang, and Guanyun Long.
• Reproductive Medicine Center, Department of Obstetrics and Gynecology, Maoming People's Hospital, Maoming, Guangdong, China.
• Medicine (Baltimore). 2024 May 3; 103 (18): e37886e37886.

IntroductionResistant ovary syndrome (ROS) represents a rare reproductive endocrine disorder that is predominantly associated with infertility, characterized by heightened endogenous gonadotropin levels in the presence of a normal ovarian reserve. Patients with ROS typically exhibit a poor response to exogenous gonadotropins during controlled ovarian stimulation (COS). Due to the absence of a universally accepted effective COS protocol, this study aims to contribute to the existing body of literature by detailing 2 successful pregnancies achieved through conventional in vitro fertilization (c-IVF) in patients with ROS, and through retrospective analysis, seeks to elucidate the factors contributing to the successful ovarian stimulation in these cases, with the ultimate goal of establishing clinical guidelines for ROS management.Patient ConcernsThe central challenge addressed in this study pertains to the effective induction of oocyte maturation during c-IVF COS in ROS patients.DiagnosisThe study focuses on 2 infertile women diagnosed with ROS who sought to conceive via c-IVF.InterventionsThe patients were subjected to a COS protocol involving pituitary downregulation followed by ovarian stimulation using recombinant follicle-stimulating hormone (r-FSH) and human menopausal gonadotropin (HMG), preceded by 3 cycles of hormone replacement therapy (HRT) pretreatment.OutcomesThe proposed protocol elicited a favorable ovarian response, culminating in the retrieval of numerous mature oocytes and the development of multiple viable embryos via c-IVF, ultimately leading to successful live births post-embryo transfer.ConclusionsOur study suggests that the outlined COS protocol may serve as a viable treatment option for ROS patients aspiring to conceive through c-IVF, thereby potentially expanding the therapeutic repertoire for this challenging condition.Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.

16 keywords...

hide…